Rethinking PH-ILD: What Emerging Data Could Mean for Patient Care
Jean M. Elwing, MD, FCCP
Recognizing Pulmonary Hypertension in Interstitial Lung Disease
Moving the Needle in oHCM: The Era of Cardiac Myosin Inhibitors
Nosheen Reza, MD
Anjali Tiku Owens, MD
Pieter Martens, MD, MSc, PhD
Real-World Evidence: Effectiveness of Finerenone in Reducing UACR in Patients With CKD and Type 2 Diabetes
Csaba P. Kovesdy, MD
Examining the Link Between Surgical Menopause and Heart Failure
Elise Shalowitz, MS
Navigating Chronic Anticoagulation Reversal in Cardiothoracic Surgery
Brian P. McDonough, MD, FAAFP
Ahmet Kilic, MD FACS
Heart Transplant in ATTR-CM: A New Look at Referral and Candidacy
Steve Jackson, PharmD
Alex Reyentovich, MD
Adapting CV Risk Reduction Strategies for Cancer Survivorship
Stephanie Dixon, MD, MPH
Reducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Bruno Batinica, MD
Exploring AI-Powered ATTR-CM Detection
Anticoagulation Reversal Decisions in Cardiothoracic Surgery: Case-Based Insights
Charles Turck, PharmD, BCPS, BCCCP
Akshay Kumar, MD
Updated AACE Guidance on Managing Dyslipidemia in T2D
Scott D. Isaacs, MD FACP, FACE
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
Applying Guideline Recommendations to ACS Management
Sunil Rao, MD
The Role of TTR Stabilization in ATTR-CM Treatment
Sumeet Mitter MD, MSc, FACC
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.